Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)

被引：166

作者：

Collins, Peter W. ^{[1
]}

Chalmers, Elizabeth ^{[2
]}

Hart, Daniel P. ^{[3
]}

Liesner, Ri ^{[4
]}

Rangarajan, Savita ^{[5
]}

Talks, Kate ^{[6
]}

Williams, Mike ^{[7
]}

Hay, Charles R. ^{[8
]}

机构：

[1] Cardiff Univ, Univ Wales Hosp, Sch Med, Cardiff CF10 3AX, S Glam, Wales

[2] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland

[3] Queen Mary Univ, Royal London Hosp, London Sch Med & Dent, London, England

[4] Great Ormond St NHS Trust, London, England

[5] Hampshire Hosp NHS Fdn Trust, Basingstoke & N Hampshire Hosp, Basingstoke, Hants, England

[6] Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England

[7] Birmingham Childrens Hosp NHS Fdn Trust, Birmingham, W Midlands, England

[8] Cent Manchester Univ Hosp, Manchester, Lancs, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2013年 / 160卷 / 02期

关键词：

haemophilia; inhibitor; immune tolerance induction; haemostasis; factor VIII; IX; bypassing agents; RECOMBINANT FACTOR-VIII; PREVIOUSLY UNTREATED PATIENTS; IMMUNE TOLERANCE INDUCTION; ACTIVATED FACTOR-VII; B-DOMAIN DELETION; F8 GENE MUTATION; A PATIENTS; PROPHYLACTIC TREATMENT; ORTHOPEDIC-SURGERY; RISK-FACTORS;

D O I：

10.1111/bjh.12091

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：153 / 170

页数：18

共 131 条

[1] Best evidence on B-domain deletion and the immunogenicity of recombinant factor VIII [J].

Aledort, L. M. ;

Navickis, R. J. ;

Wilkes, M. M. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (11) :2325-2327

[2] Can B-domain deletion alter the immunogenicity of recombinant factor VIII? A meta-analysis of prospective clinical studies [J].

Aledort, L. M. ;

Navickis, R. J. ;

Wilkes, M. M. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (11) :2180-2192

[3] Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VII inhibitor bypass activity [J].

Aledort, LM .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (10) :1700-1708

[4] Rituximab and desensitization for a patient with severe factor IX deficiency, inhibitors, and history of anaphylaxis [J].

Alexander, Sarah ;

Hopewell, Steve ;

Hunter, Susan ;

Chouksey, Akhilesh .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2008, 30 (01) :93-95

[5] The Malmo International Brother Study (MIBS): further support for genetic predisposition to inhibitor development [J].

Astermark, J ;

Berntorp, E ;

White, GC ;

Kroner, BL .

HAEMOPHILIA, 2001, 7 (03) :267-272

[6] A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study [J].

Astermark, Jan ;

Donfield, Sharyne M. ;

DiMichele, Donna M. ;

Gringeri, Alessandro ;

Gilbert, Steven A. ;

Waters, Jennifer ;

Berntorp, Erik .

BLOOD, 2007, 109 (02) :546-551

[7] Early prophylaxis/FVIII tolerization regimen that avoids immunological danger signals is still effective in minimizing FVIII inhibitor developments in previously untreated patients - long-term follow-up and continuing experience [J].

Auerswald, G. ;

Bidlingmaier, C. ;

Kurnik, K. .

HAEMOPHILIA, 2012, 18 (01) :E18-E20

[8]

Batlle J, 1999, HAEMOPHILIA, V5, P431

[9] Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry [J].

Baudo, Francesco ;

Collins, Peter ;

Huth-Kuehne, Angela ;

Levesque, Herve ;

Marco, Pascual ;

Nemes, Laszlo ;

Pellegrini, Fabio ;

Tengborn, Lilian ;

Knoebl, Paul ;

Aspoeck, G. ;

Heistinger, M. ;

Knobl, P. ;

Makipernaa, A. ;

André, H. ;

Aouba, A. ;

Bellucci, S. ;

Beurrier, P. ;

Borg, J. Y. ;

Darnige, L. ;

Devignes, J. ;

d'Oiron, R. ;

Gautier, P. ;

Gay, V. ;

Girault, S. ;

Gruel, Y. ;

Guerin, V. ;

Hézard, N. ;

Khellaf, M. ;

Koenig, M. ;

Lévesque, H. ;

Lifermann, F. ;

Marlu, R. ;

Ninet, J. ;

Peynet, J. ;

Quemeneur, T. ;

Rothschild, C. ;

Schleinitz, N. ;

Sigaud, M. ;

Trouillier, S. ;

Voisin, S. ;

Giebl, A. ;

Holstein, K. ;

Huth-Kuhne, A. ;

Loreth, R. M. ;

Steigerwald, U. ;

Tiede, A. ;

Theodossiades, G. ;

Nemes, L. ;

Radvanyi, G. ;

Schlammadinger, A. .

BLOOD, 2012, 120 (01) :39-46

[10] Importance of rapid bleeding control in haemophilia complicated by inhibitors [J].

Berntorp, E. .

HAEMOPHILIA, 2011, 17 (01) :11-16

← 1 2 3 4 5 6 7 8 9 10 →